Cited by 71MRI in cancer diagnosisRadiomics and Machine Learning in Medical ImagingAI in cancer detection

Using computer‐extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage

Open access
Burnside, Elizabeth S., Drukker, Karen, Li, Hui, Bonaccio, Ermelinda, Zuley, Margarita, Ganott, Marie, Net, Jose M., Sutton, Elizabeth J. +12 more·2016·Cancer

Abstract

BACKGROUND: The objective of this study was to demonstrate that computer‐extracted image phenotypes (CEIPs) of biopsy‐proven breast cancer on magnetic resonance imaging (MRI) can accurately predict pathologic stage. METHODS: The authors used a data set of deidentified breast MRIs organized by the National Cancer Institute in The Cancer Imaging Archive. In total, 91 biopsy‐proven breast cancers were analyzed from patients who had information available on pathologic stage (stage I, n = 22; stage II, n = 58; stage III, n = 11) and surgically verified lymph node status (negative lymph nodes, n = 46; ≥ 1 positive lymph node, n = 44; no lymph nodes examined, n = 1). Tumors were characterized according to 1) radiologist‐measured size and 2) CEIP. Then, models were built that combined 2 CEIPs to predict tumor pathologic stage and lymph node involvement, and the models were evaluated in a leave‐1‐out, cross‐validation analysis with the area under the receiver operating characteristic curve (AUC) as the value of interest. RESULTS: Tumor size was the most powerful predictor of pathologic stage, but CEIPs that captured biologic behavior also emerged as predictive (eg, stage I and II vs stage III demonstrated an AUC of 0.83). No size measure was successful in the prediction of positive lymph nodes, but adding a CEIP that described tumor “homogeneity” significantly improved discrimination (AUC = 0.62; P = .003) compared with chance. CONCLUSIONS: The current results indicate that MRI phenotypes have promise for predicting breast cancer pathologic stage and lymph node status. Cancer 2016;122:748–757. © 2015 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.29791

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Burnside, E. S., Drukker, K., Li, H., Bonaccio, E., Zuley, M., Ganott, M., Net, J. M., Sutton, E. J., Brandt, K. R., Whitman, G. J., Conzen, S. D., Lan, L., Ji, Y., Zhu, Y., Jaffe, C. C., Huang, E. P., Freymann, J. B., Kirby, J. S., Morris, E. A., & Giger, M. L.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Chicago (US)
  • Roswell Park Comprehensive Cancer Center (US)
  • University of Pittsburgh (US)
  • University of Miami (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Mayo Clinic (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Department of Radiology University of Chicago Chicago Illinois
  • Endeavor Health (US)
  • National Institutes of Health (US)
Corresponding author
  • Morris, Elizabeth A.
  • Giger, Maryellen L.
Venue
Cancer
Publisher
Wiley
Published
2015-11-30
Volume
122
Issue
5
Pages
748-757
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2184968530
Cited by
71
References
35
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 2
FWCI
5.40
Type
journal article
Language
en
Open access
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institutes of Health (R01CA165229, R01LM010921, K24CA194251, T32 EB002103)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
breast cancer, breast MRI, lymph node status, tumor size, radiomics, The Cancer Imaging Archive
MeSH terms
Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Image Processing, Computer-Assisted, Lymph Nodes, Magnetic Resonance Imaging, Middle Aged, Neoplasm Staging, Phenotype, Prognosis, ROC Curve, Carcinoma, Ductal, Breast, Carcinoma, Lobular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review